<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-18T07:52:14Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:20.500.12327/2761" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:20.500.12327/2761</identifier><datestamp>2025-10-22T11:24:19Z</datestamp><setSpec>com_2072_4428</setSpec><setSpec>com_2072_4427</setSpec><setSpec>col_2072_487898</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Quantification of camelid cytokine mRNA expression in PBMCs by microfluidic qPCR technology</dc:title>
   <dc:creator>Rodon, Jordi</dc:creator>
   <dc:creator>Te, Nigger</dc:creator>
   <dc:creator>Ballester, Maria</dc:creator>
   <dc:creator>Segalés, Joaquim</dc:creator>
   <dc:creator>Serra Gironella, Joan</dc:creator>
   <dc:creator>Bensaid, Albert</dc:creator>
   <dc:contributor>Producció Animal</dc:contributor>
   <dc:contributor>Genètica i Millora Animal</dc:contributor>
   <dc:contributor>Sanitat Animal</dc:contributor>
   <dc:subject>619</dc:subject>
   <dc:description>Camelids are economically and socially important in several parts of the world and might carry pathogens with&#xd;
epizootic or zoonotic potential. However, biological research in these species is limited due to lack of reagents.&#xd;
Here, we developed RT-qPCR assays to quantify a panel of camelid innate and adaptive immune response genes,&#xd;
which can be monitored in a single run. The assays were validated with PHA, PMA-ionomycin, and Poly I:Cstimulated PBMCs from alpaca, dromedary camel and llama, including normalization by multiple reference&#xd;
genes. Further, comparative gene expression analyses for the different camelid species were performed by a&#xd;
unique microfluidic qPCR assay. Compared to unstimulated controls, PHA and PMA-ionomycin stimulation&#xd;
elicited robust Th1 and Th2 responses in PBMCs from camelid species. Additional activation of type I and type III&#xd;
IFN signalling pathways was described exclusively in PHA-stimulated dromedary lymphocytes, in contrast to&#xd;
those from alpaca and llama. We also found that PolyI:C stimulation induced robust antiviral response genes in&#xd;
alpaca PBMCs. The proposed methodology should be useful for the measurement of immune responses to&#xd;
infection or vaccination in camelid species.</dc:description>
   <dc:description>This study was performed as part of the Zoonotic Anticipation and Preparedness Initiative (ZAPI project) [Innovative Medicines initiative (IMI) grant 115760] and the Veterinary Biocontained research facility Network (VetBioNet) project (EU Grant Agreement INFRA-2016-1 Nº731014), with assistance and financial support from IMI and the European Commission and contributions from EFPIA partners. J.R. was partially supported by the VetBioNet project. IRTA is supported by CERCA Programme/Generalitat de Catalunya.</dc:description>
   <dc:description>info:eu-repo/semantics/acceptedVersion</dc:description>
   <dc:date>2023-09-17</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:identifier>Rodón, Jordi, Nigeer Te, María Ballester, Joaquím Segalés, Júlia Vergara‐Alert, and Albert Bensaïd. 2023. “Quantification of Camelid Cytokine mRNA Expression in PBMCs by Microfluidic qPCR Technology.” Developmental and Comparative Immunology 149: 105061. doi:10.1016/j.dci.2023.105061.</dc:identifier>
   <dc:identifier>0145-305X</dc:identifier>
   <dc:identifier>http://hdl.handle.net/20.500.12327/2761</dc:identifier>
   <dc:identifier>https://doi.org/10.1016/j.dci.2023.105061</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Developmental and Comparative Immunology</dc:relation>
   <dc:relation>EC/PF7/115760/EU/Zoonotic Anticipation and Preparedness Initiative/ZAPI</dc:relation>
   <dc:relation>EC/H2020/731014/EU/Veterinary Biocontained facility Network for excellence in animal infectiology research and experimentation/VetBioNet</dc:relation>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>44</dc:format>
   <dc:publisher>Elsevier</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>